A detailed history of Versant Capital Management, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 321 shares of DXCM stock, worth $28,273. This represents 0.01% of its overall portfolio holdings.

Number of Shares
321
Holding current value
$28,273
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$65.68 - $81.01 $21,083 - $26,004
321 New
321 $24,000
Q4 2023

Jan 08, 2024

BUY
$75.49 - $124.16 $1,207 - $1,986
16 Added 66.67%
40 $4,000
Q3 2023

Oct 11, 2023

BUY
$86.06 - $137.93 $344 - $551
4 Added 20.0%
24 $2,000
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $1,019 - $1,993
15 Added 300.0%
20 $1,000
Q1 2022

Apr 29, 2022

SELL
$94.08 - $130.2 $282 - $390
-3 Reduced 37.5%
5 $3,000
Q2 2021

Jul 22, 2021

BUY
$80.99 - $107.93 $80 - $107
1 Added 14.29%
8 $3,000
Q1 2021

Apr 27, 2021

BUY
$84.79 - $104.74 $169 - $209
2 Added 40.0%
7 $3,000
Q1 2020

Apr 17, 2020

SELL
$47.79 - $75.63 $47 - $75
-1 Reduced 16.67%
5 $1,000
Q3 2019

Oct 18, 2019

SELL
$35.53 - $43.8 $1,385 - $1,708
-39 Reduced 86.67%
6 $0
Q2 2019

Jul 16, 2019

BUY
$27.84 - $38.92 $83 - $116
3 Added 7.14%
45 $6,000
Q1 2019

Apr 23, 2019

BUY
$28.07 - $38.18 $1,038 - $1,412
37 Added 740.0%
42 $5,000
Q1 2019

Apr 23, 2019

SELL
$28.07 - $38.18 $1,038 - $1,412
-37 Reduced 88.1%
5 $5,000
Q3 2017

Apr 23, 2018

SELL
$11.36 - $18.98 $102 - $170
-9 Reduced 17.65%
42 $2,000
Q2 2017

Apr 23, 2018

BUY
N/A
9 Added 21.43%
51 $3,000
Q3 2016

Apr 23, 2018

SELL
N/A
-5 Reduced 10.64%
42 $3,000
Q4 2015

Apr 23, 2018

BUY
N/A
47
47 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.